Orange Park Medical Center First In Northeast Florida To Offer New Procedure To Treat Artery Blockages
Orange Park Medical Center is the first facility in Northeast Florida to bring a new treatment option to patients with coronary artery disease. The Diamondback 360® Coronary Orbital Atherectomy System is a FDA approved device used for treatment of plaque buildup in the arteries. According to the Centers for Disease Control and Prevention, coronary heart disease is the most common type of heart disease, killing over 370,000 people annually.
The device is used in a pre-stenting procedure where the arterial passageways containing calcified coronary lesions are sanded to clear a pathway for a stent. Previously, a patient may have required open heart surgery to clear large blockages. The stent is then placed in the artery, allowing for increased blood flow to the heart.
“Orange Park Medical Center is on the forefront of providing pioneering technology for their patients with cardiovascular conditions,” said Dr. Omer Zuberi, a Board Certified Interventional Cardiologist, who performed the first procedure. “This device is most beneficial for patients with severely calcified blockages in their arteries that do not qualify for open heart surgery, giving patients another solution that before could not have been treated.”
Orange Park Medical Center was also the first facility in Northeast Florida to implant a new miniaturized, wireless monitoring sensor to manage heart failure (HF) in May 2015. The CardioMEMS HF System allows patients to transmit daily sensor readings from their homes to their health care providers allowing for personalized and proactive management to reduce the likelihood of hospitalization.
“Orange Park Medical Center is committed to improve patient care by investing in innovative medical technology and top quality practices.” said Kelly Lindsay, Director of Cardiovascular Services. “Orange Park Medical Center works to find solutions for successful patient outcomes in the diagnosis or treatment of coronary artery disease.”